首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes
【24h】

Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes

机译:糖尿病性增生性视网膜病变与2型糖尿病患者的微量白蛋白尿有关

获取原文
获取外文期刊封面目录资料

摘要

Diabetic retinopathy is one of the leading causes of blindness in working-age individuals. Diabetic patients with proteinuria or those on dialysis usually present severe forms of diabetic retinopathy, but the association of diabetic retinopathy with early stages of diabetic nephropathy has not been entirely established. A cross-sectional study was conducted on 1214 type 2 diabetic patients to determine whether microalbuminuria is associated with proliferative diabetic retinopathy in these patients. Patients were evaluated by direct and indirect ophthalmoscopy and grouped according to the presence or absence of proliferative diabetic retinopathy. The agreement of diabetic retinopathy classification performed by ophthalmoscopy and by stereoscopic color fundus photographs was 95.1% (kappa = 0.735; P < 0.001). Demographic information, smoking history, anthropometric and blood pressure measurements, glycemic and lipid profile, and urinary albumin were evaluated. On multiple regression analysis, diabetic nephropathy (OR = 5.18, 95% CI = 2.91-9.22, P < 0.001), insulin use (OR = 2.52, 95% CI = 1.47-4.31, P = 0.001) and diabetes duration (OR = 1.04, 95% CI = 1.01-1.07, P = 0.011) were positively associated with proliferative diabetic retinopathy, and body mass index (OR = 0.90, 95% CI = 0.86-0.96, P < 0.001) was negatively associated with it. When patients with macroalbuminuria and on dialysis were excluded, microalbuminuria (OR = 3.3, 95% CI = 1.56-6.98, P = 0.002) remained associated with proliferative diabetic retinopathy. Therefore, type 2 diabetic patients with proliferative diabetic retinopathy more often presented renal involvement, including urinary albumin excretion within the microalbuminuria range. Therefore, all patients with proliferative diabetic retinopathy should undergo an evaluation of renal function including urinary albumin measurements.
机译:糖尿病性视网膜病是工作年龄个体失明的主要原因之一。患有蛋白尿的糖尿病患者或接受透析的糖尿病患者通常表现出严重的糖尿病性视网膜病变,但糖尿病性视网膜病变与糖尿病性肾病早期的关联尚未完全确立。对1214名2型糖尿病患者进行了一项横断面研究,以确定这些患者中微量白蛋白尿是否与糖尿病性视网膜增生病相关。通过直接和间接检眼镜对患者进行评估,并根据是否存在增生性糖尿病视网膜病变对患者进行分组。通过眼底镜检查和立体彩色眼底照片进行的糖尿病性视网膜病变分类的一致性为95.1%(k = 0.735; P <0.001)。人口统计学信息,吸烟史,人体测量和血压测量,血糖和血脂概况和尿白蛋白进行了评估。在多元回归分析中,糖尿病肾病(OR = 5.18,95%CI = 2.91-9.22,P <0.001),胰岛素使用(OR = 2.52,95%CI = 1.47-4.31,P = 0.001)和糖尿病病程(OR = 1.04,95%CI = 1.01-1.07,P = 0.011)与增生性糖尿病视网膜病变呈正相关,而体重指数(OR = 0.90,95%CI = 0.86-0.96,P <0.001)呈负相关。当排除具有白蛋白尿和透析的患者时,微量白蛋白尿(OR = 3.3,95%CI = 1.56-6.98,P = 0.002)仍与增生性糖尿病视网膜病变相关。因此,患有增生性糖尿病视网膜病变的2型糖尿病患者更常出现肾脏受累,包括微量白蛋白尿范围内的尿白蛋白排泄。因此,所有患有增生性糖尿病视网膜病变的患者都应接受肾功能评估,包括尿白蛋白测量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号